Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2024| Title: | Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand | Authors: | Trubiano, J. A. Cheng, A. C. Korman, T. M. Roder, C. Campbell, A. Ferguson, J. K. Blackmore, T. K. Riley, T. V. Athan, E. Blyth, C. C. May, M. L. A. |
Issue Date: | 2016 | Source: | 46, (4), 2016, p. 479-493 | Pages: | 479-493 | Journal: | Internal Medicine Journal | Abstract: | The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.L6097612802016-04-19 | DOI: | 10.1111/imj.13027 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L609761280&from=exporthttp://dx.doi.org/10.1111/imj.13027 | | Keywords: | adult;alternative medicine;antibiotic therapy;article;Australia and New Zealand;child;clinical trial (topic);Clostridium difficile infection;colonoscopy;diagnostic test;disease severity;fecal microbiota transplantation;feces microflora;human;incidence;infection prevention;medical society;Clostridioides difficile;physician;practice guideline;priority journal;systematic review;recurrent infection;NCT01241552antibiotic agent;auranofin;beta lactam antibiotic;beta lactamase inhibitor;bezlotoxumab;cadazolid;cephalosporin derivative;clindamycin;fidaxomicin;immunoglobulin;lincosamide;metronidazole;monoclonal antibody;nitazoxanide;probiotic agent;proton pump inhibitor;ramoplanin;rifaximin;surotomycin;thuricin;tigecycline;vancomycin;acute diarrhea | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.